CCND3 and osteosarcoma: It has been reported that aberrant cyclin D3 expression was found in various cancers, including leukemia, hepatocellular carcinoma, gliomas, bladder carcinoma, prostate cancer, osteosarcoma and breast cancer [85, 86].